Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy With CD19ζ Gene-modified EBV-specific CTLs After Stem Cell Transplant in Children With High-risk Acute Lymphoblastic Leukaemia

NCT01195480 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT01195480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01195480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy With CD19ζ Gene-modified EBV-specific CTLs After Stem Cell Transplant in Children With High-risk Acute Lymphoblastic Leukaemia
Lead sponsor
University College, London
Phase
Phase 1/2
Overall status
Terminated
Start date
May 31, 2012
Completion date
November 30, 2015
Enrollment
29 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia